ARCHIVES

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014

NCI advisory panel recommends funding a 10-year Human Cancer Genome Project with $1.35 billion in new money.

March 18, 2005

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990

Obituary: Joseph Burchenal, 93, A Leader In Cancer Drug Development at MSKCC.

March 17, 2006

Senate Kills Construction Reprograming Plan; NCI To Seek Limit On Future Grant Applications

March 18, 1977

Chemo+Radiation Preserves Voice, RTOG Study Finds

December 26, 2003